Literature DB >> 27883006

Dyslipidaemia: Apo-AI infusion after acute MI.

Gregory B Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27883006     DOI： 10.1038/nrcardio.2016.192

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).

Authors:  C Michael Gibson; Serge Korjian; Pierluigi Tricoci; Yazan Daaboul; Megan Yee; Purva Jain; John H Alexander; P Gabriel Steg; A Michael Lincoff; John J P Kastelein; Roxana Mehran; Denise M D'Andrea; Lawrence I Deckelbaum; Bela Merkely; Maciej Zarebinski; Ton Oude Ophuis; Robert A Harrington
Journal:  Circulation       Date:  2016-11-15       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.